Clinical Trial Update: Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era

View source ↗

Summary

Completed a clinical trial evaluating Non-Hodgkin lymphoma in patients over 80 years old in the Rituximab era. The update summarizes the study outcomes and impl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Oncology Specialists, S.C. | Conditions: Non-Hodgkin's Lymphoma | Status: COMPLETED